SCHEMBL9575544

SCHEMBL9575544

CCOCCOCOCCOCC

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.46
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766133 0.96 ALDH1A1 (0.47) ALDH1A1TSHRTHRB
SCHEMBL1229107 0.96 ALDH1A1 (0.47) ALDH1A1TSHRTHRB
SCHEMBL8767050 0.96 ALDH1A1 (0.47) ALDH1A1TSHRTHRB
SCHEMBL7174265 0.96 ALDH1A1 (0.47) ALDH1A1TSHRTHRB
SCHEMBL5694827 0.92 ALDH1A1 (0.42) ALDH1A1TSHRTHRB
SCHEMBL15384206 0.89 ALDH1A1 (0.40) ALDH1A1TSHRTHRB
SCHEMBL19970453 0.88 ALDH1A1 (0.60) ALDH1A1TSHRTHRB
SCHEMBL22247 0.88
SCHEMBL16298619 0.87 ALDH1A1 (0.41) ALDH1A1TSHRTHRB
SCHEMBL28355209 0.87 ALDH1A1 (0.41) ALDH1A1TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107239006-B Resist stripping liquid composition, flat plate, method for manufacturing flat plate, and display device 东友精细化工有限公司 2020-09-01 CN claimed
CN-107239006-B Resist stripping liquid composition, flat plate, method for manufacturing flat plate, and display device 东友精细化工有限公司 2020-09-01 CN disclosed
US-9796655-B2 Method for producing carbonate compound ASAHI GLASS COMPANY, LIMITED (JP) 2017-10-24 US disclosed
US-9796655-B2 Method for producing carbonate compound ASAHI GLASS COMPANY, LIMITED (JP) 2017-10-24 US disclosed
US-20150284314-A1 METHOD FOR PRODUCING CARBONATE COMPOUND ASAHI GLASS COMPANY, LIMITED (JP) 2015-10-08 US disclosed
US-20150284314-A1 METHOD FOR PRODUCING CARBONATE COMPOUND ASAHI GLASS COMPANY, LIMITED (JP) 2015-10-08 US disclosed
US-8956768-B2 Nonaqueous electrolyte comprising one or more hydrofluoroethers and one or more non-fluoroethers, and a secondary cell containing the nonaqueous electrolyte ASAHI GLASS COMPANY, LIMITED (JP) 2015-02-17 US disclosed
US-8956768-B2 Nonaqueous electrolyte comprising one or more hydrofluoroethers and one or more non-fluoroethers, and a secondary cell containing the nonaqueous electrolyte ASAHI GLASS COMPANY, LIMITED (JP) 2015-02-17 US disclosed
US-20120214073-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES, AND SECONDARY BATTERY ASAHI GLASS COMPANY, LIMITED (JP) 2012-08-23 US disclosed
US-20120214073-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES, AND SECONDARY BATTERY ASAHI GLASS COMPANY, LIMITED (JP) 2012-08-23 US disclosed
US-20110020700-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY CELL, AND SECONDARY CELL ASAHI GLASS COMPANY, LIMITED (JP) 2011-01-27 US disclosed
US-20110020700-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY CELL, AND SECONDARY CELL ASAHI GLASS COMPANY, LIMITED (JP) 2011-01-27 US disclosed
US-5225550-A PROCESS FOR THE PREPARATION OF SUBSTITUTED ACYCLIC NUCLEOSIDES, AND INTERMEDIATES OCCURRING THEREIN HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284314-A1 METHOD FOR PRODUCING CARBONATE COMPOUND CA9, CA11, CA2 ALDH1A1 4677/4885TSHR 3961/4885THRB 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.